Article Versions Notes

Iovino C, Mastropasqua R, Lupidi M, Bacherini D, Pellegrini M, Bernabei F, Borrelli E, Sacconi R, Carnevali A, D’Aloisio R, et al. Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature. Pharmaceutics. 2020; 12(8):703. https://doi.org/10.3390/pharmaceutics12080703

Iovino, Claudio, Rodolfo Mastropasqua, Marco Lupidi, Daniela Bacherini, Marco Pellegrini, Federico Bernabei, Enrico Borrelli, Riccardo Sacconi, Adriano Carnevali, Rossella D’Aloisio, and et al. 2020. "Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature" Pharmaceutics 12, no. 8: 703. https://doi.org/10.3390/pharmaceutics12080703

Iovino, C., Mastropasqua, R., Lupidi, M., Bacherini, D., Pellegrini, M., Bernabei, F., Borrelli, E., Sacconi, R., Carnevali, A., D’Aloisio, R., Cerquaglia, A., Finocchio, L., Govetto, A., Erba, S., Triolo, G., Di Zazzo, A., Forlini, M., Vagge, A., & Giannaccare, G. (2020). Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature. Pharmaceutics, 12(8), 703. https://doi.org/10.3390/pharmaceutics12080703